rs9332736
|
C2;CYP21A2;C2-AS1
|
COMPLEMENT COMPONENT 2 DEFICIENCY
|
A |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs558702
|
C2;CYP21A2;ZBTB12
|
Diabetes Mellitus, Insulin-Dependent
|
|
0.700 |
GeneticVariation |
GWASDB |
A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene.
|
17632545 |
2007 |
rs9267665
|
C2;CYP21A2;ZBTB12
|
Diabetes Mellitus, Insulin-Dependent
|
|
0.700 |
GeneticVariation |
GWASDB |
A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene.
|
17632545 |
2007 |
rs558702
|
C2;CYP21A2;ZBTB12
|
Adenocarcinoma of lung (disorder)
|
|
0.700 |
GeneticVariation |
GWASDB |
A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma.
|
19836008 |
2009 |
rs1042663
|
C2;CYP21A2;C2-AS1
|
Rheumatoid Arthritis
|
|
0.700 |
GeneticVariation |
GWASDB |
A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis.
|
21156761 |
2011 |
rs2734335
|
C2;CYP21A2
|
Rheumatoid Arthritis
|
|
0.700 |
GeneticVariation |
GWASDB |
A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis.
|
21156761 |
2011 |
rs497239
|
C2;CYP21A2;C2-AS1
|
Rheumatoid Arthritis
|
|
0.700 |
GeneticVariation |
GWASDB |
A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis.
|
21156761 |
2011 |
rs497309
|
C2;CYP21A2
|
Rheumatoid Arthritis
|
|
0.700 |
GeneticVariation |
GWASDB |
A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis.
|
21156761 |
2011 |
rs498240
|
C2;CYP21A2
|
Rheumatoid Arthritis
|
|
0.700 |
GeneticVariation |
GWASDB |
A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis.
|
21156761 |
2011 |
rs511294
|
C2;CYP21A2
|
Rheumatoid Arthritis
|
|
0.700 |
GeneticVariation |
GWASDB |
A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis.
|
21156761 |
2011 |
rs544167
|
C2;CYP21A2
|
Rheumatoid Arthritis
|
|
0.700 |
GeneticVariation |
GWASDB |
A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis.
|
21156761 |
2011 |
rs550605
|
C2;CYP21A2;C2-AS1
|
Rheumatoid Arthritis
|
|
0.700 |
GeneticVariation |
GWASDB |
A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis.
|
21156761 |
2011 |
rs558702
|
C2;CYP21A2;ZBTB12
|
Rheumatoid Arthritis
|
|
0.700 |
GeneticVariation |
GWASDB |
A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis.
|
21156761 |
2011 |
rs609061
|
C2;CYP21A2;C2-AS1
|
Rheumatoid Arthritis
|
|
0.700 |
GeneticVariation |
GWASDB |
A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis.
|
21156761 |
2011 |
rs621701
|
C2;CYP21A2;C2-AS1
|
Rheumatoid Arthritis
|
|
0.700 |
GeneticVariation |
GWASDB |
A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis.
|
21156761 |
2011 |
rs644045
|
C2;CYP21A2
|
Rheumatoid Arthritis
|
|
0.700 |
GeneticVariation |
GWASDB |
A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis.
|
21156761 |
2011 |
rs659445
|
C2;CYP21A2;EHMT2
|
Rheumatoid Arthritis
|
|
0.700 |
GeneticVariation |
GWASDB |
A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis.
|
21156761 |
2011 |
rs116477171
|
C2;CYP21A2
|
Serum total cholesterol measurement
|
C |
0.700 |
GeneticVariation |
GWASCAT |
A large electronic-health-record-based genome-wide study of serum lipids.
|
29507422 |
2018 |
rs116477171
|
C2;CYP21A2
|
Low density lipoprotein cholesterol measurement
|
C |
0.700 |
GeneticVariation |
GWASCAT |
A large electronic-health-record-based genome-wide study of serum lipids.
|
29507422 |
2018 |
rs116477171
|
C2;CYP21A2
|
Triglycerides measurement
|
C |
0.700 |
GeneticVariation |
GWASCAT |
A large electronic-health-record-based genome-wide study of serum lipids.
|
29507422 |
2018 |
rs151340617
|
C2;CYP21A2;C2-AS1
|
COMPLEMENT COMPONENT 2 DEFICIENCY
|
|
0.700 |
GeneticVariation |
UNIPROT |
A novel type II complement C2 deficiency allele in an African-American family.
|
9670930 |
1998 |
rs28934590
|
C2;CYP21A2
|
COMPLEMENT COMPONENT 2 DEFICIENCY
|
|
0.700 |
GeneticVariation |
UNIPROT |
A novel type II complement C2 deficiency allele in an African-American family.
|
9670930 |
1998 |
rs547154
|
C2;CYP21A2;C2-AS1
|
Polypoidal choroidal vasculopathy
|
|
0.050 |
GeneticVariation |
BEFREE |
A SNP (rs547154) in the C2 gene and three SNPs (rs541862, rs2072633, rs4151667) in the CFB gene were genotyped, and case-control studies were performed in subjects with these PCV subtypes.
|
24965207 |
2014 |
rs138195505
|
C2;CYP21A2
|
Age related macular degeneration
|
|
0.020 |
GeneticVariation |
BEFREE |
Abnormal regulation of the complement system likely caused by the Y402H polymorphism in the complement factor H gene is a recognized risk factor for AMD, as is the A69S variant in the poorly characterized LOC387715 gene.
|
17576744 |
2007 |
rs497309
|
C2;CYP21A2
|
Marginal Zone B-Cell Lymphoma
|
|
0.010 |
GeneticVariation |
BEFREE |
Additionally, SNPs (C2 rs497309, A>C and C3 rs344550, G>C) in two complement genes were positively associated with marginal zone lymphoma (MZL) and C1QG was associated with CLL/SLL, but these results were based on a limited number of cases.
|
22170086 |
2012 |